Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Acute Schizophrenia
Clinical trial NCT02054702 · COMPLETED
Trial details
- NCT number
- NCT02054702
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-02-01
- Primary completion
- 2014-06-01
- Enrollment
- 97
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.